Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease

Published:2022-07-29 Issue: Volume:11 Page:1-10
ISSN:1740-4398
Container-title:Drugs in Context
language:
Short-container-title:DIC

Author:

Metro Giulio,De Giglio Andrea,Ricciuti Biagio,Siringo Marco,Marinelli Daniele,Gelibter Alain,Pecci Federica,Berardi Rossana,Cantini Luca,Di Federico Alessandro,Andrini Elisa,Mosca Mirta,Lamberti Giuseppe,Brambilla Marta,Mountzios Giannis

Publisher

BioExcel

Subject

Pharmacology,Molecular Medicine,General Medicine

Link

https://www.drugsincontext.com/wp-content/uploads/2022/07/dic.2022-3-9.pdf

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancer;Journal of Medical Economics;2024-02-24

2. The expanding scenario of advanced non-small-cell lung cancer between emerging evidence and clinical tasks;Drugs in Context;2023-05-02

3. Overexpression of TWF1 promotes lung adenocarcinoma progression and is associated with poor prognosis in cancer patients through the MMP1 signaling pathway;Journal of Thoracic Disease;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP